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Abstract
Objective—To determine whether slower walking speed was associated with increased risk of
incident hip and knee osteoarthritis (OA)-related outcomes.
Methods—After providing informed consent, community-dwelling participants in the Johnston
County Osteoarthritis Project completed two home-based interviews and an additional clinic visit
for radiographic and physical evaluation. One thousand eight hundred fifty eight non-
institutionalized residents age 45 years or older living for at least one year in one of six townships
in Johnston County, North Carolina completed the study’s questionnaires and clinical
examinations at baseline and at follow-up testing. Walking time was assessed using a manual
stopwatch in 2 trials over an 8 foot distance, and walking speed was calculated as the average of
both trials. For the hip and knee, we examined 3 outcomes per joint site: radiographic OA (weight-
bearing anteroposterior knee radiographs, supine anteroposterior pelvic radiographs of the hip);
chronic joint symptoms; and symptomatic OA. Covariates included age, gender, race, education,
marital status, body mass index, number of self-reported, health care provider-diagnosed chronic
conditions, number of prescriptions, depressive symptoms, self-rated health, number of lower-
body functional limitations, smoking, and physical activity.
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Results—Faster walking speed was consistently associated with lower incidence of radiographic
(adjusted odds ratio [aOR]=0.88, 95% confidence interval [CI]=0.79–0.97) and symptomatic knee
OA (aOR=0.84, 95% CI=0.75–0.95); slower walking speed was associated with greater incidence
of these outcomes across a broad range of different clinical and radiographic OA outcomes.
Conclusion—Slower walking speed may be a marker for incident knee OA, but other studies
must confirm this finding.
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Habitual walking speed is an excellent predictor of future hospitalization, disability, and
death, with slower speeds increasing these risks across a spectrum of age groups, functional
abilities, chronic conditions, and types of health outcomes [1–10]. The mechanisms by
which walking speed are related to health are unknown. Speed of walking may be a marker
of general health and physical functioning or could have specific biological and/or
mechanical effects over time. Few studies have looked at walking speed’s associations with
incident morbidities occurring early in the disablement process. Examining these
associations may improve our understanding of whether slower walking also may be
associated with disabling disease over time.
Habitual walking speed may be a predictor or early marker of osteoarthritis (OA), a joint
disease associated with pain and functional limitations with typical onset in mid-life.
Increased joint stresses occur with faster walking speeds [11, 12], and repetitive high-level
dynamic joint loading has been shown to contribute to chondrocyte death [13] and the
development of OA in animal models [14]. Faster walking speed in combination with
abnormal joint biomechanics may further amplify dynamic joint loading [11] and may
accelerate joint degeneration. Decreasing walking speed has been suggested as a mechanism
used by individuals with knee pathologies to reduce loading and pain in the medial
compartment of the knee [15]. In cross-sectional analyses, individuals with knee or hip OA
walk more slowly with smaller stride lengths and greater stance duration than those with
healthy joints [16–19].
Before OA is evident on clinical examination or with diagnostic images, individuals may
exhibit signs of early disease, particularly poorer functional abilities, including slower
walking speed. OA can be defined in a variety of ways, and its definition is evolving
because radiographic findings and symptoms do not always correlate. Here, we defined OA-
related outcomes in 3 ways: radiographic OA (rOA), a standard in the field [20–23]; chronic
joint symptoms; and symptomatic OA--the presence of chronic joint symptoms and rOA in
the same joint [23, 24].
The purpose of this study was to determine whether habitual walking speed is associated
with the risk of incident hip and knee OA-related outcomes over an average 6 year follow-
up period. Faster walking speeds may contribute to greater aberrant mechanical effects at the
knee and hip over time and, in turn, be associated with incident hip and knee OA-related
outcomes. Alternatively, based on the complexities of defining OA and a short mean follow-
up time (which may not be adequate for a healthy joint to develop OA), slower walking
speed may be a marker of pre-clinical disease and would be associated with incident hip and
knee-OA related outcomes.
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Briefly, the Johnson County Osteoarthritis Project is a community-based cohort study of hip
and knee OA among community residents aged 45 and older, recruited by probability
sampling of Caucasian and African-Americans in 6 townships of Johnston County, North
Carolina [24, 25]. After giving informed consent, participants completed home interviews
and a clinic visit for radiographic and physical evaluation. The baseline cohort of 3,187
residents was assembled from 1991–1997 (T0), with follow-up of 1858 participants from
1999–2004 (T1). The 1,329 lost to follow-up included: emigration from study area (N=161),
refusals (N=435), physically or mentally unable to participate (N=234), death (N=411), and
inability to locate, following search of local death indices and the National Death Index
(N=88). The mean time from baseline to follow-up was 6.1 years (standard deviation=1.4
years, range=3.6–13.3 years). Compared to participants who returned for the follow-up visit,
those who did not return were more likely to be men (42.2% vs. 34.8%, Chi-square p<0.01),
African American (36.2% vs. 29.8%, Chi-square p<0.01), and older at baseline (mean age
63.7 years vs. 60.2 years, t-test p<0.01).
Measures
Primary Outcome (Dependent) Variables—Radiographic and joint symptom data
were used to define the 5 primary outcome variables. Bilateral weight-bearing
anteroposterior radiography of the knee with foot mat placement was performed, as
previously described [24]. Women age 50 or older and all men completed supine
anteroposterior pelvic radiography; women under age 50 did not complete baseline pelvic
radiographs to limit radiation exposure to their reproductive tissues, and thus, data for
women under 50 were not available for radiographic and symptomatic hip OA analyses
(n=216 from the 1858 with baseline and follow-up data). Radiographs were rated by a bone
and joint radiologist (JBR) using the Kellgren-Lawrence (K-L) radiographic atlas for knee
and hip radiographic grades [21, 22]. Inter-rater and intra-rater reliability for the radiologist
were high (weighted kappa 0.86 and 0.89, respectively) [25]. K-L grades range from 0 to 4
(none, questionable, mild, moderate or severe OA); rOA was defined by K-L grades ≥ 2.
Chronic joint symptoms were defined as a participant’s “Yes” response to the question: “On
most days do you have pain, aching or stiffness in your [left/right] [knee/hip]?”
Symptomatic OA of a hip or knee was defined by presence of rOA and self-reported chronic
joint symptoms in the same joint. Isolated rOA was defined as rOA without presence of
chronic joint symptoms, and isolated chronic joint symptoms as incident chronic joint
symptoms without presence of rOA.
Three non-mutually exclusive analytic cohorts (sub-samples) were created to assess
different incident outcomes (Figure 1). First, we identified the 860 participants free of any
rOA at baseline (Sub-sample I), which allowed us subsequently to estimate incident rOA,
regardless of symptoms. Second, we identified the 1,195 participants who were free of
symptomatic OA at baseline (Sub-sample II), that is, they may have had chronic joint
symptoms without rOA, rOA without chronic joint symptoms, or neither. This cohort
allowed us to estimate incident symptomatic OA among those with none or just one
component of the definition. Third, we identified 396 participants free of baseline hip or
knee chronic joint symptoms and also free of baseline rOA (Sub-sample III). This allowed
us to simultaneously estimate incident radiographic and symptomatic OA as well as two new
outcomes--the incidence of isolated chronic joint symptoms and isolated rOA—in a cohort
more likely to be free of subclinical OA at baseline.
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Primary Independent Variable—Walking time was assessed using a manual stopwatch
in 2 trials over an 8 foot distance; the 2 trials were averaged and walking speed in meters/
second was calculated. Participants also reported whether they experienced pain during the
test (“pain during walking test”—see Table 1), which was entered into models as a potential
confounder. The 8 foot walk test has been reported to have good reliability among adults
60+ years of age, with intra-class correlation coefficients (ICC) of 0.79 [26] and 0.72 [27]
for intra-observer reliability and ICC= 0.52 for inter-observer reliability [27]
Covariates—All covariates were measured at baseline and were included because they
relate or may relate to walking speed or OA-related outcomes. Education and marital status
were used as proxies for socioeconomic status; income data were not available for the whole
sample. Age, gender, race (Caucasian versus African American), education (≤ high school
graduate versus other) current marital status (married versus not married), and measured
body mass index (BMI; weight in kilograms/height in meters squared [kg/m2]) were
described. The number of 13 self-reported physician-diagnosed chronic conditions (asthma,
tuberculosis, chronic bronchitis, emphysema, “other” lung conditions, hypertension, stroke,
high cholesterol, myocardial infarction, cancer, anemia, diabetes, and Parkinson’s disease)
were summed and grouped (0, 1, 2, 3+), along with the number of prescription medications
(0, 1–2, 3+). Depressive symptoms were assessed using the Centers for the Epidemiological
Studies of the Elderly Depression Scale (CESD, range 0–60) [28]. Self-rated health was
recorded as excellent, good, fair or poor. To control for potential confounding by existing
functional limitations that might influence walking speed or mobility, self-reported
(primarily lower-body) functional limitations were selected from the Health Assessment
Questionnaire [29], and the number of limitations was summed for items involving dressing,
standing, transferring bed to chair, walking outside, up five steps, lifting 5 pounds, running
errands or shopping, transferring in and out of a car, doing chores, bathing, and toileting (0,
1–2, 3+). Current smoking (yes/no) and any physical activity (yes/no response to the
question “During the past month, did you participate in any physical activities or exercises
such as running, calisthenics, golf, gardening, or walking for exercise?”) were also recorded.
Statistical Analysis—Incident cases of OA-related outcomes were identified, and logistic
regression was used to estimate the effect of baseline walking speed (increment in the odds
ratio per each clinically meaningful increment of walking speed, defined as 0.10 m/sec) [3]
on OA-related outcomes. This definition of walking speed has been shown to be an
important walking speed difference between individuals that is related to poorer health
outcomes. All analyses were adjusted for age, gender, race, education, marital status, BMI,
number of comorbidities, depressive symptoms, number of medications, physical activity
level, current smoking, self-rated health, pain during walking speed trials, and number of
lower body limitations. To explore the effect of an alternate definition of rOA on estimates,
we conducted post-hoc sensitivity analyses with K-L ascertainment of rOA of scores of 1 or
more (which typically are not regarded as indicative of rOA). All analyses used performed
using STATA 10.0/SE. Additionally, the inclusion of men, but not women, from the 45–50
years age range may bias results of the hip OA outcomes, and we conducted post-hoc
sensitivity analyses to compare hip OA outcome results with and without the men under the
age of 50 (N=341). The adjusted models included many covariates, and we considered the
addition of baseline injury, although the covariates of lower body limitations and pain with
walking likely accommodated this potential confounder. We conducted a post-hoc
sensitivity analysis comparing results with and without injury as a covariate.
RESULTS
Table 1 shows baseline characteristics of the overall study cohort and the three sub-samples.
For the overall cohort, the average age was 60.1 years. The majority were female, white,
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married and without more than a high school diploma. Approximately one-fourth rated their
health as fair or poor and, on average, participants were overweight (mean BMI=29.2 kg/m2
[30]. Depressive symptoms were low (median=3) [28]. Approximately 15% had 3 or more
comorbidities, 36% were taking 3 or more prescription medications, 18% were current
smokers, and 46% did not have any physical activity. Almost one-third reported lower body
functional limitations. Baseline mean walking speed (0.87m/s) was slower than reported
normal speeds of 1.2 m/s for healthy older adults (65 + years old) and also below 1.0 m/s,
which is highly predictive of 1-year mortality in population-based cohorts of adults 70–79
years of age [9].
As expected, sub-samples I-III were generally healthier than the overall cohort, since
individuals with prevalent OA-related outcomes at baseline were removed from the
population at risk (those with rOA at baseline were removed from sub-sample I, those with
symptomatic OA were removed from sub-sample II, and those with any symptoms or
radiographic findings in any knee or hip joint were removed from sub-sample III). Table 1
shows that sub-sample III had the best self-rated health, least comorbidity and medication
use, lowest self-reported lower body functional limitations, fastest walking speeds, and the
lowest frequencies of pain while walking.
Table 2 shows the results of the logistic regression analyses in the three sub-samples. The
results are presented as an incremental increase of gait speed, showing an inverse
association between faster walking speed and knee OA outcomes. An inverse association
between faster walking speed and incident OA implies a positive relationship between
slower walking speed and incident OA. In 2a–c, results are shown first for the incident OA
outcome (or, for Subsample III, outcomes) at any joint in the sub-sample, followed by
outcomes in either knee and either hip at T1 follow-up. (Results for the left and right knee
and hip are shown in Supplementary Table S1.) Table 2a, for example, shows that faster
walking speed was generally associated with lower incident rOA at either knee, but not at
either hip; thus, slower walking speed is associated with higher incident knee rOA. Table 2b
shows that in those at risk for symptomatic OA (Subsample II), faster baseline walking
speeds also were associated with lower incident symptomatic OA at the knee (i.e., slower
walking speed associated with higher incident symptomatic knee OA) but not the hip.
Finally, Table 2c shows the healthiest cohort, i.e., those least likely to be biased by
subclinical disease. Faster walking speed again was significantly associated with lower
incident rOA at the knee (i.e., slower walking speed associated with higher incident knee
rOA), but not at the hip. Faster speed was also associated with lower incident isolated rOA
at either joint site (see data in Table 2c for incident rOA at T1 and for incident isolated rOA
at T1). ORs for incident symptomatic knee OA, other measures of incident isolated rOA,
and incident isolated symptoms showed no statistically significant associations.
Results of post-hoc sensitivity analyses with rOA defined as K-L grade of 1 or more at
baseline (Supplementary Table S2) could only be reasonably estimated for symptomatic OA
outcomes due to small counts for radiographic OA and radiographic OA/joint symptoms
outcomes. The symptomatic OA outcomes defined as K-L grade of 1 or more did not differ
substantially from results presented in this paper using a definition of K-L grade of 2 or
more. Post-hoc sensitivity analyses comparing results with and without the men under the
age of 50 (Supplementary Table S3) and results with and without history of injury
(Supplementary Table S4) also reveal similar estimates.
DISCUSSION
The principal result from the current study is that in a cohort of mid-to-older age adults,
slower walking speeds (in increments that have been previously demonstrated to be
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clinically significant between individuals, i.e., 0.10 m/sec as described above) are associated
with higher incidence of radiographic and symptomatic knee OA, while faster walking
speeds appear to be associated with lower incidence. Estimates in a smaller subsample
designed to eliminate possible preclinical disease supported this result. There were no
significant findings of walking speed related to hip OA-related outcomes.
A number of studies suggest that faster walking speeds might alter the overall biomechanics
of walking. Biomechanical studies have shown increased angular excursions at the knee
during the swing phase of faster versus slower walking, at least partly due to higher passive
coriolis and centrifugal forces [31], possibly resulting in altered alignment at heel strike (i.e.,
decreased knee extension) for slower versus faster walking. The relative contributions of
different muscles and muscle activation patterns also appear to play a functional role in the
known altered biomechanics of faster versus slower walking [31]. Faster walking results in a
decrease in the percentage of the walking cycle spent in stance phase (62.6% at self-selected
normal speed versus 60.6% at faster speed) [32], which would decrease the total duration of
weight bearing load on a joint over time [33]. Studies of children and young adults have
demonstrated that joint moments and powers in the lower extremity are increased with faster
walking speeds [34, 35], although patterns of joint loading and muscle activation differ
among older adults [36–38]. Finally, there is a relatively greater magnitude of lower
extremity musculotendinous activity and coactivation at the knee and ankle observed among
older adults during faster versus slower walking speed [36] which may increase joint loading
or may provide more stability to the joints to help attenuate overall joint moments (e.g.,
cushioning) [31].
Interestingly, our results -- that slower walking is associated with higher incidence of knee
OA are not consistent with a hypothesis that the mechanical effects of faster walking may
have contributed to the development of knee or hip OA in this study and also are counter to
recent hypotheses that reduced walking speed and/or “mindfulness walking” may help to
reduce peak adduction moments and joint loads at the knee [39, 40],and also help reduce
knee joint symptoms [41]. Most of these studies are cross-sectional, with some investigators
supporting, but others more neutral, on slower walking as an appropriate intervention to
decrease knee joint loads.
Our findings may have important implications for prevention and treatment because
pharmaceutical and exercise interventions have documented impact on walking speed [42].
During fast walking, the rate of joint loading increases, as well as the rate of energy
absorption, particularly at the knee [43]. A healthy knee joint (one that does not have OA)
would theoretically be able to tolerate a greater rate of joint loading. In a knee joint with
damaged or weakened articular cartilage, faster walking may not be tolerated because the
cartilage is less able to dissipate forces [44]. Potentially, individuals without radiographic or
symptomatic OA at baseline in this study may have had early joint changes that were not
detectable. If so, such individuals may have slower self-selected walking speeds, as
observed at baseline, to reduce the rate of joint loading, and possibly later developed
detectable OA. The individuals who could walk more quickly at baseline may have also
maintained better joint health during the study, contributing to decreased OA at follow-up.
In an attempt to adjust for potential confounder effects, we controlled for lower extremity
joint limitations and self-reported pain during walking test, and examined progressively
more restricted (i.e., healthier) cohorts to reduce prevalent OA as a possible explanation for
our findings.
One novel result of this study was the discrepancy in effects at the knee and hip. Incidence
of hip OA is estimated to be approximately 88 per 100,000 person-years, compared to 240
per 100,000 person-years at the knee [45]. The lower outcome incidence rates of the hip
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compared to the knee would reduce the power of this study to detect significantly significant
associations, but not the magnitude of the association Neither the magnitude nor the
direction of our hip ORs suggest the potential presence of a real effect at the hip. Possibly,
the knee is more susceptible than the hip to joint load variations that occur with slower and
faster walking speeds, as previously suggested by studies that report an association between
obesity (resulting in a greater joint load) and knee OA [20], but inconsistently with hip OA
[46]. Our results suggest that slower walking speed is likely a better marker for identifying
those at risk of developing OA-related outcome for the knee but not for the hip.
General strengths of this study include the large, community cohort, the prospective study
design, adequate representation of Caucasians and African Americans, and the fact that case
ascertainment at baseline and follow-up was confirmed by clinical and radiographic
assessment. In addition, in Sub-sample III, we were able to create a cohort more likely to be
free of possible subclinical disease and report for the first time the simultaneous incidence of
radiographic and symptomatic OA as well as the onset of isolated rOA and isolated
symptoms.
There are several limitations as well. First, we do not have data on OA at other important
lower extremity locations (ankles/feet) that could potentially impact our findings, and there
were no lower extremity muscular strength, kinematic, or kinetic data collected that would
allow us to further explore our findings. Anterior-posterior films of the knee were available,
but other views, such as patellofemoral joint films, were not included in this analysis;
alternate views may have provided additional evidence of radiographic disease of the knee.
Second, the definition of OA (K-L grade ≥ 2) is primarily driven by the presence of an
osteophyte, although osteophyte formation may not be the first feature that develops in all
individuals. Assessments of individual radiographic features (i.e., separate examination of
osteophyte formation or joint space narrowing) and their location (medial or lateral
compartment) were not available for this cohort during the study period. Third, we assume
that a clinically important difference in walking speed for individuals (0.10 m/sec) is also an
important difference in walking speed when comparing populations. Previous work in the
geriatrics literature has shown that differences between individuals in walking speed in
increments as small as 0.10 m/sec are clinically significant for survival and functional
mobility [3]. There is little in the literature assessing important differences in walking
speeds when comparing populations, but in a study of older veterans hospitalized for
geriatric evaluation and management, each positive difference in walking speed at hospital
admission of 0.10 m/s between people was associated with improved physical function as
indicated by a 4.5 point higher standardized Short Form-36 score, 2.1 point higher
standardized Physical Functioning subscale score on the Short Form-36, and 0.63 fewer total
activities of daily living (ADL) disabilities [3]. Fourth, approximately 40% of participants
did not return for follow-up. Participants who did not return tended to be slightly older,
African-American, and male compared to those who completed the follow-up visit. Analysis
was limited to participants who were more likely to be younger and healthier at baseline,
possibly biasing the association.
Although our analyses controlled for a variety of potential confounders, residual
confounding is always possible in observational research. A randomized clinical trial design
of a walking speed intervention and incident OA-related outcomes might more clearly
describe the nature of the associations we observed and perhaps suggest additional avenues
for future intervention development, although this type of study would require many years
of observation.
Given the consistency of our findings across the different subsamples, walking speed may
be a marker of knee joint health. We recommend further research to confirm these findings
Purser et al. Page 7













and consideration of walking speed assessment during clinic visits as a means to help
identify patients at greatest risk of developing OA, especially at the knee, and who may
benefit from pharmaceutical and/or preventive interventions. Other performance-based
measures and self-report physical function measures should be explored in future research to
determine their utility alone and in combination with walking speed for identifying those at
risk of developing lower extremity OA.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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• Habitual walking speed has been shown to be a strong predictor of
hospitalization, mortality, and a variety of morbidities, but few studies have
examined the association between walking speed and disabling conditions, like
osteoarthritis (OA), over time.
• Individuals with OA may have early signs of the disease, such as slower
walking speed or other functional impairments, well before OA is detectable on
examination or on diagnostic images.
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• Slower walking speed may be a marker of poorer knee joint health. This marker
may assist in the identification of individuals at greater risk for knee OA who
may benefit from pharmaceutical and/or preventive interventions.
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Composition of the three baseline incidence samples used in analysis.
*Subsamples are not mutually exclusive.
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Table 1
Selected Characteristics of the Study Sample and Sub-samples









Case number 1858 860 1195 396
Mean Follow-Up Time (SD*) in
years
6.1 (1.4) 5.9 (1.4) 6.0 (1.4) 5.8 (1.3)
Age (SD*)in years 60.07 (9.86) 58.90 (8.43) 58.76 (9.11) 58.51 (8.73)
% Gender
 Male 34.8 40.3 38.5 46.2
 Female 65.2 59.7 61.5 53.8
% Race
 White 70.2 75.2 72.2 72.5
 Black 29.8 24.8 27.8 27.5
% Education
 1–12 years 68.4 66.6 64.5 59.6
 13+ years 31.6 33.4 35.5 40.4
% Marital status
 Married 64.5 69.7 69.2 70.2
 Not currently married 35.5 30.3 30.8 29.8
% Self-rated health
 Excellent 25.3 29.4 30.3 37.1
 Good 48.2 47.8 50.1 50.0
 Fair or poor 26.5 22.8 19.6 12.9
Mean (SD*)Body Mass Index in
kilograms/meter2
29.18 (5.91) 28.43 (5.01) 28.31 (5.14) 28.00 (5.09)
Median Depressive symptoms (IQR†) 3 (8) 3 (8) 3 (7) 2 (6)
% Number of Comorbidities
 0 32.0 33.3 35.8 39.5
 1 32.1 33.8 34.0 35.0
 2 21.2 20.9 19.1 18.6
 3+ 14.7 12.0 11.1 6.9
% Number of prescribed medications
 0 27.7 31.3 33.3 40.2
 1–2 37.3 36.4 37.8 34.8
 3+ 36.0 32.3 28.9 25.0
% Any physical activity
 No 45.7 42.1 42.0 42.4
 Yes 54.3 57.9 58.0 57.6
% Lower body limitation
 0 65.2 69.9 76.0 88.5
 1–2 14.0 13.2 11.1 7.7
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 3+ 20.8 16.9 12.9 3.8
% Currently smoking
 No 82.1 80.3 81.3 81.0
 Yes 17.9 19.7 18.7 19.0
Mean walking speed (meters/second) 0.87 (0.28) 0.93 (0.27) 0.92 (0.27) 0.98 (0.26)
% Pain during walking test?
 No 82.8 88.4 90.6 96.6
 Yes 17.2 11.6 9.4 3.4
Note: Sub-sample I is free of radiographic OA at baseline; sub-sample II is free of symptomatic OA at baseline; sub-sample III is free of
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Table 2
The Impact of Faster (per 0.1 m/sec) Baseline Walking Speed on Incidence of OA-related outcomes
OA Incidence (percentage) Adjusted OR 95% CI
a) Sub-sample I: 860 Subjects without Radiographic OA (K-L grade 2+) at T0
Incident Radiographic OA at T1
Any joint radiographic OA 214/835 (25.6) 0.93 [0.86, 1.02]
---Either knee radiographic OA 148/849 (17.4) 0.88† [0.79, 0.97]
---Either hip radiographic OA 83/842 (9.9) 1.01 [0.90, 1.13]
b) Sub-sample II: 1195 Subjects without Symptomatic OA at T0
Incident Symptomatic OA at T1
Any joint symptomatic OA 167/1156 (14.5) 0.92 [0.84, 1.01]
---Either knee symptomatic OA 118/1165 (10.1) 0.84‡ [0.75, 0.95]
---Either hip symptomatic OA 58/1174 (4.9) 1.06 [0.93, 1.20]
c) Sub-sample III: 396 Subjects without Any Radiographic OA or Joint Symptoms at T0
Incident Radiographic OA at T1 (K-L grade 2+)
Any joint radiographic OA 91/385 (23.6) 0.87† [0.76, 0.99]
---Either knee radiographic OA 61/393 (15.5) 0.82† [0.70, 0.97]
---Either hip radiographic OA 41/386 (10.6) 0.97 [0.82, 1.13]
Incident Isolated Radiographic OA at T1 (K-L grade 2+; no joint symptoms)
Any joint radiographic OA only 47/390 (12.1) 0.82† [0.69, 0.98]
---Either knee radiographic OA only 38/394 (9.6) 0.87 [0.72, 1.06]
---Either hip radiographic OA only 33/388 (8.5) 0.90 [0.75, 1.09]
Incident Symptomatic OA at T1(K-L grade 2+; positive joint symptoms)
Any joint symptomatic OA 27/394 (6.9) 0.94 [0.75, 1.17]
---Either knee symptomatic OA 20/395 (5.1) 0.78 [0.58, 1.05]
---Either hip symptomatic OA 7/395 (1.8) 1.49 [0.97, 2.27]
Incident Isolated Symptoms at T1 (symptoms; K-L grade <2)
Any joint symptoms only 93/391 (23.8) 0.99 [0.87, 1.11]
---Either knee symptoms only 74/395 (18.7) 0.96 [0.85, 1.09]





Results of modeling have been adjusted for the following variables: age, gender, race, education, marital status, self-reported health, BMI,
depressive symptoms, number of comorbidity, number of prescribed medications, participation of any physical activity, number of low body
limitations, smoking status, presence of pain during walking speed assessment.
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